--- title: Who We Are --- [Skip to content](https://ntxbio.com/who-we-are#main-content) [![](https://ntxbio.com/hs-fs/hubfs/Picture1.png?width=1224&height=332&name=Picture1.png)](https://ntxbio.com?hsLang=en) - [Technologies](https://ntxbio.com/technologies) Show submenu for Technologies - [Overview](https://ntxbio.com/technologies) - [NTxscribe® FLEX & CORE](https://ntxbio.com/ntxscribe) - [NTxpress®](https://ntxbio.com/ntxpress) - [Services](https://ntxbio.com/mrna-services) Show submenu for Services - [mRNA Services](https://ntxbio.com/mrna-services) - [Cryo-EM Services](https://ntxbio.com/cryo-em-services-1) - [Who We Are](https://ntxbio.com/who-we-are) - [News](https://ntxbio.com/news) - [Careers](https://ntxbio.com/careers) - Resources Show submenu for Resources - [NTxscribe® Whitepaper](https://ntxbio.com/ntxscribe-whitepaper) - [DNA Template Calculator](https://ntxbio.com/dna-template-calculator) Open main navigation Close main navigation - [Technologies](https://ntxbio.com/technologies) Show submenu for Technologies - [Overview](https://ntxbio.com/technologies) - [NTxscribe® FLEX & CORE](https://ntxbio.com/ntxscribe) - [NTxpress®](https://ntxbio.com/ntxpress) - [Services](https://ntxbio.com/mrna-services) Show submenu for Services - [mRNA Services](https://ntxbio.com/mrna-services) - [Cryo-EM Services](https://ntxbio.com/cryo-em-services-1) - [Who We Are](https://ntxbio.com/who-we-are) - [News](https://ntxbio.com/news) - [Careers](https://ntxbio.com/careers) - Resources Show submenu for Resources - [NTxscribe® Whitepaper](https://ntxbio.com/ntxscribe-whitepaper) - [DNA Template Calculator](https://ntxbio.com/dna-template-calculator) - [Contact us](https://ntxbio.com/contact-us) [Contact us](https://ntxbio.com/contact-us?hsLang=en) # Enabling the Future of Medicine ## World Changing. Life Saving. For Good. NTx was founded to democratize access to medicines by enabling on-demand, decentralized biomanufacturing. For too long, the development of vital therapies has been hindered by slow, complex, and centralized production methods. We were created to overcome these barriers. Our proprietary platforms utilize cell-free synthetic biology in a continuous flow system, giving researchers and drug developers unprecedented speed and control. This approach allows for the scalable production of high-integrity mRNA and proteins, accelerating timelines from discovery to commercial manufacturing. We provide the tools that clear the path from concept to cure, empowering our partners to build the future of medicine. **NTx Bio is redefining biomanufacturing to accelerate therapeutic breakthroughs. Our innovative NTxscribe® and NTxpress® platforms empower scientists worldwide by delivering accessible, high-quality, and rapidly scalable production solutions, ultimately helping bring life-saving treatments to patients faster.** ###### **SUSTAINABLE** Our biosynthesis technology is completely defined and is independent of cell lines ###### **CONSISTENT** Our results are reproducible with limited artifacts ###### **SCALABLE** Our biomanufacturing processes can be easily scaled to meet fluctuating supply needs ###### **BIOSYNTHETIC** Our platforms are built for cell-free mRNA and protein production ###### **EFFICIENT** Rapid, high-quality, and low-cost production to accelerate lead optimization, pre-clinical testing and IND filings ### Executive Team ![](https://ntxbio.com/hs-fs/hubfs/image-png-Mar-08-2025-06-04-21-0308-PM.png?width=523&height=525&name=image-png-Mar-08-2025-06-04-21-0308-PM.png) **Joan Haab** Chief Executive Officer **![SE](https://ntxbio.com/hs-fs/hubfs/SE.png?width=1654&height=1654&name=SE.png)** **Steven Evans, PhD** Chief Scientific Officer & Senior Vice President R&D   **![MR v2](https://ntxbio.com/hs-fs/hubfs/MR%20v2.png?width=347&height=371&name=MR%20v2.png)** **Marcel Roche** Chief Financial Officer ![MP v2](https://ntxbio.com/hs-fs/hubfs/MP%20v2.png?width=350&height=402&name=MP%20v2.png) **Matthew Phillips** Senior Vice President, Business Development ### Board of Directors ![](https://ntxbio.com/hs-fs/hubfs/image-png-Mar-08-2025-06-04-21-0308-PM.png?width=523&height=525&name=image-png-Mar-08-2025-06-04-21-0308-PM.png) **Joan Haab** Chief Executive Officer [![DS updated](https://ntxbio.com/hs-fs/hubfs/DS%20updated.png?width=1654&height=1654&name=DS%20updated.png)](https://21945425.hs-sites.com/david-seldin?hsLang=en) [**David Seldin**](https://ntxbio.com/david-seldin?hsLang=en) Managing Partner, Anzu Partners **[![PK](https://ntxbio.com/hs-fs/hubfs/PK.png?width=1654&height=1654&name=PK.png)](https://21945425.hs-sites.com/peter-kolchinsky?hsLang=en)**[**Peter Kolchinsky, PhD**](https://ntxbio.com/peter-kolchinsky?hsLang=en) Managing Partner, RA Capital Management **[![EL](https://ntxbio.com/hs-fs/hubfs/EL.png?width=1654&height=1654&name=EL.png)](https://21945425.hs-sites.com/edward-liddy?hsLang=en)**[**Edward Liddy**](https://ntxbio.com/edward-liddy?hsLang=en) Former Chairman & CEO, Allstate Corporation ![](https://ntxbio.com/hs-fs/hubfs/image-png-Aug-07-2025-12-12-33-8294-AM.png?width=643&height=694&name=image-png-Aug-07-2025-12-12-33-8294-AM.png) **Dave Johnson** Board Member [![TN](https://ntxbio.com/hs-fs/hubfs/TN.png?width=1654&height=1654&name=TN.png)](https://21945425.hs-sites.com/thomas-nickoloff?hsLang=en)[**Thomas Nickoloff**](https://ntxbio.com/thomas-nickoloff?hsLang=en) Managing Principal, Camino Real Capital Partners ### Scientific Advisory Board ![](https://ntxbio.com/hs-fs/hubfs/image-png-3.png?width=400&height=421&name=image-png-3.png) [**William Oh, MD**](https://ntxbio.com/william-oh?hsLang=en) Scientific Advisory Board, Chair  Yale School of Medicine  ![](https://ntxbio.com/hs-fs/hubfs/image-png-Mar-11-2025-08-08-57-7488-PM.png?width=411&height=448&name=image-png-Mar-11-2025-08-08-57-7488-PM.png) [**John P. Cooke, MD, Ph.D**](https://ntxbio.com/john-cooke?hsLang=en) Houston Methodist Research Institute **![](https://ntxbio.com/hs-fs/hubfs/image-png-Mar-10-2025-04-57-48-8630-PM.png?width=407&height=426&name=image-png-Mar-10-2025-04-57-48-8630-PM.png)** [**Yi Lin MD, Ph.D.**](https://ntxbio.com/yi-lin?hsLang=en) Mayo Clinic **![](https://ntxbio.com/hs-fs/hubfs/image-png-Mar-10-2025-05-06-11-8633-PM.png?width=406&height=451&name=image-png-Mar-10-2025-05-06-11-8633-PM.png)** [**Thomas Marron, MD, Ph.D.**](https://ntxbio.com/thomas-marron?hsLang=en) Icahn School of Medicine at Mount Sinai ![](https://ntxbio.com/hs-fs/hubfs/image-png-Mar-08-2025-06-12-48-7629-PM.png?width=410&height=433&name=image-png-Mar-08-2025-06-12-48-7629-PM.png) [**Giselle L. Saulnier Sholler, MD**](https://ntxbio.com/giselle-sholler?hsLang=en) Penn State Health / Beat Childhood Cancer Research Consortium ![](https://ntxbio.com/hs-fs/hubfs/image-png-Mar-10-2025-05-16-21-4885-PM.png?width=398&height=432&name=image-png-Mar-10-2025-05-16-21-4885-PM.png)[ **Elias Sayour, MD, Ph.D.**](https://ntxbio.com/elias-sayour?hsLang=en) University of Florida ![](https://ntxbio.com/hs-fs/hubfs/image-png-Mar-10-2025-05-24-58-3072-PM.png?width=409&height=425&name=image-png-Mar-10-2025-05-24-58-3072-PM.png)[**Padmanee Sharma, MD, Ph.D.**](https://ntxbio.com/padmanee-sharma?hsLang=en) MD Anderson Cancer Center ![](https://ntxbio.com/hs-fs/hubfs/image-png-Mar-10-2025-05-34-49-5810-PM.png?width=404&height=425&name=image-png-Mar-10-2025-05-34-49-5810-PM.png)[**Catherine J. Wu, MD**](https://ntxbio.com/catherine-wu?hsLang=en) Dana Farber Cancer Institute ![portrait_circle_transparent_trimmed](https://ntxbio.com/hs-fs/hubfs/portrait_circle_transparent_trimmed.png?width=224&height=249&name=portrait_circle_transparent_trimmed.png) **Jeff Coller, PhD** Professor of RNA Biology and Therapeutics at Johns Hopkins University #### Creating the fast lane for vital therapeutics. [![](https://ntxbio.com/hs-fs/hubfs/Picture1.png?width=1224&height=332&name=Picture1.png)](https://www.ntxbio.com?hsLang=en) NTx is enabling the future of medicine with cell-free biomanufacturing systems that drive breakthroughs in research, therapeutics, and personalized cancer vaccines. The company’s flagship NTxscribe platform brings industrial-grade RNA manufacturing to the benchtop, producing high-purity, high-integrity RNA with unmatched speed, efficiency, and scalability – all within a fully closed system. NTxscribe’s single-use RNA cartridges run on NTxbiomaterials, a proprietary line of reagents that are manufactured in the U.S. with fully domestic raw materials. **PAGES ** [Home](https://ntxbio.com/?hsLang=en) [Technologies](https://21945425.hs-sites.com/technologies?hsLang=en) [NTxscribe](https://21945425.hs-sites.com/ntxscribe?hsLang=en)® [NTxpress](https://21945425.hs-sites.com/ntxpress?hsLang=en)® [mRNA Services](https://21945425.hs-sites.com/mrna-services?hsLang=en) [Cryo-EM Services](https://ntxbio.com/cryo-em-services-1?hsLang=en) [Who We Are](https://21945425.hs-sites.com/who-we-are?hsLang=en) **RESOURCES ** [News](https://21945425.hs-sites.com/?hsLang=en) [Careers](https://job-boards.greenhouse.io/ntx) [Contact](https://21945425.hs-sites.com/contact-us?hsLang=en) [DNA Template Calculator](https://ntxbio.com/dna-template-calculator?hsLang=en)   [Follow us on LinkedIn](https://www.linkedin.com/company/ntxbio) Copyright ©  2016-2025 by Nature's Toolbox, Inc. | Nature's Toolbox, NTx, NTxBio, NTxpress, NTxscribe and NTxbiomaterials are registered trademarks of NTx